International Journal of Neonatal Screening Events Announce Your Event Here
14–17 October 2018 11th ISNS European Regional Meeting
Scientific and technological advancements are rapidly enabling neonatal screening for ever more congenital conditions to become available. We very much look forward to hearing about some of these in this conference. The potential to significantly expand the scope of newborn screening reminds us that it is also worthwhile taking a step back and reviewing experience acquired by earlier newborn screening programmes. The keyword here is reliability. Reliability applies to all aspects of the screening process - analytical reliability (is our methodology in order?), clinical reliability (do we identify affected infants efficiently?), cost-effectiveness reliability (do we get value for money?) and more.
As the conference programme is gradually developed screening for new conditions will be highlighted with an important emphasis on reliability.
15–16 June 2018 25th Annual Meeting of German Society of Newborn Screening
we are pleased to invite you to the 25 th Annual Meeting of the German Society for Newborn Screening (DGNS). Noteworthy, this meeting for the first time will take place outside of Germany – in Vienna. Thus we hope that beyond an interesting scientific program we can offer a nice cultural ambience. Moreover, we would like to take advantage of the location Vienna to foster contact and exchange to our neighboring countries.
Following the theme “review-insights-outlook”, the program will highlight achievements, focus on the present problem of recalls and false-positive results, and view into the future with the emphasis on SCID and other not yet screened conditions.
We hope you will join us and take part in the scientific program by submitting abstracts on these or related topics.
We are looking forward to meeting you and a fruitful exchange of opinions and experience.
22–24 May 2018 6th International Molecular Diagnostics Europe
9–12 May 2018 52th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
the AEPC Working Groups, with broad and in - depth coverage of the varied topics of interest in our field. Highlights will include the Update Course on Transposition of the Great Arteries, and several sessions co-organized by multiple AEPC Working Groups, which will provide all-around coverage of important issues including morphology, imaging, as well as catheter and surgical interventions.
30 November–1 December 2017 3rd Annual Reproductive Genetic Diagnostics
Hyatt Regency Cambridge, Cambridge, MA
Couples undergoing infertility treatments are more aware than ever of preimplantation genetic screening and diagnosis, yet patients and practitioners alike are still struggling with understanding the technologies being used, their capabilities and limitations, and their clinical, legal, and ethical implications. Cambridge Healthtech Institute’s Third Annual Reproductive Genetic Diagnostics conference aims to highlight a number of technologies and their differences, as well as how effective they are at uncovering a variety of genetic abnormalities. Considerations for mosaic embryos, biopsy techniques, and genetic counseling will also be discussed. Special attention will be paid to expanded carrier screening, its role in the direct-to-consumer market, and the potential for other molecular tests for infertility and implantation failure. Future directions for the role of gene editing and non-invasive embryo diagnostics will also be discussed.
28–29 November 2017 5th Annual Advances in Prenatal Molecular Diagnostics
Hyatt Regency Cambridge, Cambridge, MA
Cell-free DNA-based screening and the potential for cell-based screening has upended the field of prenatal testing. While cell-free tests are being used more and more in the clinic, cell-based tests are still on the cusp of commercialization. With both types of tests still in need of improvements in order to truly replace invasive tests, the near-term challenge is determining where the field heads once both options are viable. This meeting will discuss updated comparisons and examine the implementation, insurance, and clinical challenges associated with each test.
Furthermore, with advances in DNA amplification and sequencing comes greater opportunity to garner more information. Much discussion needs to take place in regards to the role of preconception counseling, expanded carrier screening, whole genome versus whole exome sequencing, and the effect these and any prenatal testing may have on the decision to continue a pregnancy or perform fetal therapy.
10–13 September 2017 2017 Newborn Screening and Genetic Testing Symposium
New Orleans, Louisiana, USA
The meeting will address state, national and international newborn screening, genetic testing and policy issues important to national and global public health. This conference is sponsored by: The Association of Public Health Laboratories, and co-sponsored by The Louisiana State Public Health Laboratory and International Society for Neonatal Screening.
5–8 September 2017 13th International Congress of Inborn Errors of Metabolism
Rio De Janeiro, Brazil
29 November–1 December 2016 Fourth Annual Advances in Prenatal Molecular Diagnostics
Boston Marriott Cambridge, Cambridge, MA, USA
Research into testing based on isolation of fetal cells from maternal blood has been underway for decades, and the discussion has been couched in terms of “if this approach can be commercialized”. At this meeting last year, for the first time, the conversation shifted to “when this approach is commercialized” as numerous groups reported substantial progress in achieving reliable isolation that would make this possible. Updated comparisons and examination of these issues, and the implementation of these different approaches, will again make for lively discussion and insight into where this field is headed and ways for researchers, test providers, clinicians and clinics to take these developments into consideration.
11–14 September 2016 9th ISNS International Meeting & 10th ISNS European Regional Meeting
The Hague, The Netherlands
3–4 June 2016 23rd Annual Meeting of the German Society for Neonatal Screening (DGNS)
The main topic of the conference will be, “New Target Disorders in Newborn Screening”. There will be talks about Cystic Fibrosis, pilot screening programs for tyrosinaemia typ-I, methylmalonic acidaemia, propionic acidaemia, creatin synthesis disorders, and disorders of remethylation.